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Abstract
Introduction: Patient activation can promote partnership
working between people with diabetes and their healthcare
professionals. We sent to people with diabetes a person-
alised, structured information booklet containing the results
of their latest nine key care processes in order to inform and
activate them. We present the findings of a survey to assess
the utility of this report, with an analysis of the association
of non-response to the survey, a surrogate for poorer patient
activation, with adverse diabetes and clinical outcomes. 
Methods: All 14,559 people with diabetes in the Wolver-
hampton health economy received a mailed report of the re-
sults of their latest nine diabetes care processes. Of these,
6,282 patients aged <75 years were mailed this report twice;
1000 of these 6,282 patients were selected randomly to re-
ceive a structured questionnaire to assess the report’s effec-
tiveness. 
Results: Of 1,000 patients, 419 (42%) responded (mean age
62±10 years, 246 males, 249 Caucasians, 389 had type 2 dia-
betes). Patients found this report useful (89%), a source of
knowledge (78%), a source of increased confidence (74%)
and it helped them understand their diabetes (78%). Non-
response was associated with significantly higher surrogate
markers of micro- and macrovascular risk.
Conclusion: A structured and personalised diabetes report,
without direct professional or health service intervention,
may improve the understanding and confidence of people
with diabetes in their self-care and it may help to activate
them to take a stronger partnership role in their health care.
Non-response as a marker of patient activation is associated
with increased clinical risk.  
Br J Diabetes 2016;16:179-184
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Introduction
The increasing burden of long-term conditions such as diabetes1
has increased emphasis on improved self-management.2,3 Care
planning is a high priority in modern healthcare, but achieving
an equal partnership between healthcare professionals and peo-
ple with diabetes needs a clear understanding of the nature of
the transaction and certainly not the imposition of a plan by the
healthcare professional.4-7 An effective partnership requires en-
ablement, empowerment and engagement of the person with
diabetes within a transactional model based on concordance,
rather than compliance.8
The concept of patient activation encompasses engagement,
empowerment and enablement,9 but seeks to extend this to the
measure of specific outcomes, indicating that the person with di-
abetes has become demonstrably active in their own healthcare.
Patient activation may be considered as an outcome of diabetes
care provision in its own right,10 as people who are engaged and
actively involved in the management of a long-term condition
have better outcomes.11 Such empowerment is conventionally
sought via diabetes education aimed at improving knowledge,
awareness and expertise in self-care, facilitating engagement in
the proposed dialogue. Unfortunately, the provision of structured
education for people with diabetes in the UK is suboptimal with
uncertain outcomes,12,13 and outcomes from current care planning
processes are also little understood.14 Other client-focused inter-
ventions promoting health literacy, self-care, access, care experi-
ence, service development and, not least, decision making have
been found to be effective,15 including pre-consultation informa-
tion,16-18 goal setting19 and organisational measures.20,21 The pro-
vision of written, individualised information is known to have a
positive effect in diabetes consultations.22 A person with diabetes
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provided with good information can enhance their own knowl-
edge,23 perhaps enhancing further their need to know and act.
Written information is valued,24 but it remains unclear if such
information per se can activate people with diabetes (in the sense
that we have defined). Accordingly, we have recently demon-
strated the perceived benefit to patients and doctors alike of a
structured information booklet in the setting of specialist clinic
consultations and care planning in our local model of diabetes
care, Wolverhampton Interface Care, Knowledge Empowered
Diabetes (WICKED).25 We also demonstrated in a large ran-
domised controlled trial (RCT) that this booklet was associated
with a significant increase in patient activation.26
We have surveyed the impact of a booklet providing up-to-
date information on the results of nine care processes among peo-
ple with diabetes. Responding to the survey may be a potential
marker of patient activation, and we have also analysed the asso-
ciations between failing to respond and adverse diabetes and car-
diovascular outcomes. We believe this to be the first report of the
perspective of people with diabetes regarding such information
delivered across a whole health economy, independently of the
influence of healthcare professional input. It is also, we believe,
the first report of the association of adverse diabetes outcomes
in relationship to a potential marker of patient activation inde-
pendent of selection bias relating to surveys in patients who
attend care.
Methods
A structured diabetes report, ‘My Diabetes, My Information, My
Plan’, containing individualised information about nine key care
processes in diabetes was designed by a three-phase develop-
ment process, as described previously.25 It contained person-
specific information on the nine key diabetes processes that
inform UK National Health Service (NHS) diabetes healthcare
delivery: HbA1c, body mass index (BMI), blood pressure, urinary
albumin:creatinine ratio (ACR), serum creatinine, serum choles-
terol, recorded smoking status, digital retinal photography and
foot examination. The booklet is available to view online at
www.wdconline.org.uk. Each process was scored as 1 if missing
and 0 if completed within a 15-month period. Each individual
thus had a summary score calculated to assess the accrued
process failure, the Failed Process Score (FPS), with range 0–9. 
The FPS is used as a direct measure of patient activation, with
outcome data from the process measures recorded for the 15-
month time frame. Primary coronary heart disease (CHD) risk
was calculated using the Framingham method where complete
data were available. Secondary macrovascular risk status was de-
fined as the presence of cardiovascular, cerebrovascular or pe-
ripheral vascular disease. Data were accrued into the local
diabetes information system via data linkage with multiple other
systems including the primary care data warehouse. The rolling
processes of data quality management have already been pub-
lished, showing a very high level of data accuracy (>95%).27
The study follows on from our previously reported RCT in-
volving 14,559 people with diabetes.26 The structured report
containing individualised information was initially sent to 8,725
people with diabetes in Wolverhampton in the active limb of a
RCT which has reported positive 3-month outcomes.26 The mail-
ing was subsequently repeated after 3 months and, at this stage,
included all people with diabetes in Wolverhampton. We se-
lected all patients aged <75 years who had received the booklet
twice (n=6,282) followed by a further random selection of 1,000
patients (by Excel 2011 random number generation), and sent
them a questionnaire to evaluate the booklet. Initial non-respon-
ders received a reminder after 2 weeks and the receipt of returns
was closed at 4 weeks. It is the response to this questionnaire
that is used as a potential second measure of patient activation. 
Data were analysed (SPSS Version 22) using the Student's
t-test (means) or the chi-squared test (proportions) with statistical
significance taken at p<0.05. Primary 10-year CHD risk was
reanalysed in univariate regression analysis after log conversion
(non-normal distribution) in order to adjust for age differences
between groups.  
Results
Subjects
There were no significant differences for any demographic or
other characteristic (Table 1) between those who were surveyed
(n=1,000) and those who were not (n=5,282).  
Of the 1,000 people surveyed, 419 responded. Non-respon-
Table 1 Demographic and clinical parameters of those 
randomly selected to be surveyed (with p values 
comparing responders vs. non-responders) and those 
not surveyed 
Not Surveyed
surveyed
(n=5,282) Responders Non- p
(n=419) responders
(n=581)
Age (years) 58.5±10 62±10 56±12 <0.001
Males 3,012 (57) 246 (59) 318 (55) NS
Ethnicity <0.001
Caucasian 2,868 (54) 249 (59) 293 (50)
Asian 1,329 (25) 76 (18) 175 (30)
African- 254 (5) 18 (4) 20 (3)
Caribbean 
Mixed 58 (1) 4 (1) 9 (2)
Other/ 773 (15) 72 (17) 84 (15%)
unknown
IMD score 35.5±15.7 34.4±15.8 36.3±15.3 NS 
(0.054)
Type 2 4,881 (92) 389 (93) 537 (92) NS
diabetes
Duration of 9.7±7.9 9.8±8.2 9.4±7.6 NS
diabetes 
(years)
Data shown are mean±SD or number (%).
NS, not statistically significant (p≥0.05); IMD, Index of Multiple deprivation.
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ders were younger and less likely to be of non-white Caucasian
background compared with responders, but there were no
significant differences between these groups for gender, index
of deprivation or type or duration of diabetes. 
Survey evaluation of ‘My Diabetes, My Information, 
My Plan’
The results of the evaluation of ‘My Diabetes, My Information,
My Plan’ from the 419 respondents are presented in Table 2. A
positive response was expressed for every question: 72–85% of
respondents answered ‘Yes definitely’ or ‘Yes to some extent’ to
every question relating to whether the report would improve their
own diabetes care, and 87–90% gave one of these answers to
questions relating to the utility of the report for anyone with
diabetes. A frequency of once or twice/year for the report was
supported by 85%.
Patient activation and outcomes
The FPS was significantly worse in non-responders than in re-
sponders, as was process attainment in every single one of the
nine subsidiary processes (Table 3). Among those where out-
comes were ascertainable and who had process measures within
the 15-month time frame (Table 4), non-responders had a higher
HbA1c, BMI, serum cholesterol and were more likely to be smok-
ers (there was no significant difference in mean systolic BP). Sig-
nificantly more non-responders had HbA1c >9% (74 mmol/mol)
and serum cholesterol >6 mmol/L, while there was a trend
towards a higher proportion with systolic BP >160 mmHg. The
10-year primary CHD risk score was adjusted for differences in
age between groups in univariate analysis and was significantly
worse in non-responders (Figure 1), independently of age
(F=22.2, p<0.001). However, the effect was not statistically dif-
ferent between groups within separate age bands, despite the
apparent separation among the middle age bands.  
Based on these data, an estimated 27 additional adverse car-
diovascular events might be expected to occur over the following
10 years in the non-responder group, based on their CHD risk at
the time of the evaluation. There were no significant differences
in the crude prevalence of established microvascular disease (eye,
foot or renal) or established secondary macrovascular disease. 
Discussion
The intervention we described is a simple but systematically con-
structed and personalised information booklet for people with
diabetes. In this article we have sought to evaluate this patient-
centric intervention ability to promote patient activation; to ex-
tend our understanding of the co-associations of poorer patient
activation with adverse demographic and clinical outcome; and
to reiterate the feasibility of navigating poorer patient activation
and thus potentially influence the recognised associated adverse
outcomes. 
Our explanation relates to Kilpatrick’s four levels of evalua-
tion27 (KP 1–4), bearing in mind that the meaning of evaluation
and assessment are often confused. In this context, evaluation
should be taken as what the recipients – our patients – thought
of what was done (KP 1) and assessment as being that which the
Table 2 Responses to a questionnaire relating to an individualised diabetes information booklet categorised in a 4-point scale as: ‘Yes 
definitely’; ‘Yes, to some extent’; ‘No, not really’; and ‘No, definitely not’ 
Questions Number Answered ‘Yes, 
answering definitely’ or ‘Yes, to 
each question some extent’, n (%)
Did you understand the purpose of this document and what it is meant to be used for? 397 355 (85)
Were the contents of the report easy to read and understand and do they make sense to you? 404 354 (85)
Was the information useful? 414 368 (88)
Did this information give you more knowledge about your diabetes? 410 321 (77)
Did this information help you to understand your diabetes better? 406 302 (72)
Would this information help you to improve your diabetes? 408 317 (76)
Would this information help you make changes in your diabetes? 406 316 (76)
Would this information help you feel more in charge or control of your diabetes? 412 316 (76)
Would you take this information with you to your next diabetes appointment with a doctor or a nurse? 402 312 (74)
Did you think this information will help in your next visit of diabetes review with a doctor or a nurse? 408 325 (78)
Would you like to receive information like this in the future? 409 328 (78)
How often would you like to have this report with this sort of information about your diabetes? 406 358 (85)*
Overall, do you think it is a good idea for people with diabetes to have this sort of report? 413 377 (90)
Overall, do you think people with diabetes will use this information to take better care of them? 414 365 (87)
*Responses for once/twice each year.
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service measured as an outcome relating to an intended benefit
(KP 2–4). 
In this sense, KP level 1 was initially considered in a small-
scale published pilot evaluation of the information booklet by
our patients.25 Here, a much more rigorous and systematic sur-
vey, without any form of selection bias, again indicates clearly
that people with diabetes want to have their individualised in-
formation in a structured, easily understandable format and that
they found it beneficial in a number of domains relating to their
diabetes care. We emphasise that KP-1 does not and cannot
prove that the booklet was effective in relation to patient acti-
vation, and it simply shows that patient evaluation of the booklet
was very high; they liked it, hopefully as a result of the consid-
erable effort in design and pilot testing. We acknowledge the
limitation of this evaluation, and the response rate to our survey
is a potential source of bias. The response rates to health surveys
average around 60%28 when using maximal techniques,29 with
response rates of about 50% typical of surveys with two
reminders.30 There are many confounding factors determining
response rates to surveys that are epidemiologically based, but
a crucial key factor is the resampling of populations that have
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Table 3 Failed Process Scores and uncompleted individual key 
diabetes process evaluations 
Not Surveyed
surveyed
(n=5,282) Responders Non- p
(n=419) responders
(n=581)
Failed Process 1.3±2.0 0.8±1.1 1.7±2.3 <0.001
Score
Uncompleted 
individual 
key processes
HbA1c 517 (10) 19 (5) 76 (13) <0.001
Blood 405 (8) 13 (3) 63 (11) <0.001
pressure
Body mass 644 (12) 31 (7) 97 (17) <0.001
index
Cholesterol 581 (11) 31 (7) 87 (15) <0.001
Smoking 
status 846 (16) 47 (11) 112 (19) <0.001
Retinal 
screen 832 (16) 33 (8) 120 (20) <0.001
Albumin:
creatinine 
ratio 969 (18) 53 (13) 159 (27) <0.001
Serum 
creatinine 453 (9) 15 (4) 77 (13) <0.001
Foot 
examination1343 (25) 83 (20) 167 (29) <0.01
Data shown are mean±SD or number (%).
Table 4 Diabetes and clinical outcomes 
Not Surveyed
surveyed
(n=5,282) Responders Non- p
(n=419) responders
(n=581)
HbA1c 7.7±1.7 7.5±1.4 8.0±1.9 <0.001
SBP 133±15 133±14 134±16 NS
Body mass index 31.5±7.2 30.6±6.4 32.0±6.7 <0.01
Cholesterol 4.4±1.1 4.3±1.0 4.6±1.2 <0.001
Vascular risk 1009 (19) 94 (22) 107 (18) NS
(secondary)*
Primary 10-year 13.3±7.2 12.4±6.2 13.3±7.2 NS
CHD risk†
Age-adjusted 10.7±2.1 9.3±1.8 12.0±1.8 <0.001
primary 10-year 
CHD risk (antilog) 
Current smoker 753 (14) 39 (9) 102 (18) <0.001
Albumin: 8.8±33.8 7.5±30.1 11.8±44.4 NS
creatinine ratio
Serum creatinine 85±41 85±34 84±55 NS
Retinopathy NS
Vision- 464 (10) 36 (9) 62 (13)
threatening
Background 1384 (31) 115 (30) 137 (30)
None 2602 (59) 235 (61) 262 (57)
Foot risk NS
High 551 (14) 56 (17) 55 (13)
Intermediate 1113 (28) 85 (25) 110 (27)
Low 2275 (58) 195 (58) 249 (60)
HbA1c ≥9% 835 (16) 50 (12) 113 (19) <0.001
SBP ≥160 mmHg 240 (5) 18 (4) 40 (7) NS 
(0.054)
Cholesterol ≥6 280 (5) 12 (3) 39 (7) <0.01
Any 1182 (22) 75 (18) 168 (29) <0.001
Data shown are mean±SD or number (%). 
* Presence of cardiovascular, cerebrovascular or peripheral vascular disease. 
† Assessed in individuals with sufficient data on cardiovascular risk factors for
Framingham risk scoring: 661 (not surveyed), 288 (responders), 373 (non-responders).
CHD, coronary heart disease; NS, not statistically significant (p≥0.05); SBP, systolic
blood pressure
participated in previous surveys,31 which in itself is a perverse
bias, as is the sampling of those that are engaged in care (e.g.
attenders). We thus emphasise that our survey population was
a random sample that did not differ significantly in any regard
from the wider cohort, with no selection of any description. This
mitigates the potential for bias arising from surreptitious selec-
tion, but certainly will be associated with a more realistic non-
response rate. Additionally, the findings were exactly in line with
the outcomes from our much smaller scale pilot in which the
response rate was greater than 60%.25
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We did not measure KP level 2 by intention, which would
have amounted to a knowledge test. Here, our a priori interest
was not in knowledge acquisition but in action outcomes (i.e.
performance). However, we have published the 3-month out-
comes of a large RCT equating to KP levels 3 and 4. The in-
tended benefit, a true measurable outcome – in other words,
our assessment – was demonstrating that patient activation oc-
curred as the measureable impact of the patient booklet.26 We
will shortly submit the 1-year outcomes which not only show im-
provements in failed processes but also a significant benefit in
HbA1c. To our knowledge, this is the first prospective demon-
stration of the use of an information tool (as an intervention) to
improve patient activation in that its use resulted in a significant
improvement in the completion of diabetes processes as shown
by a reduced FPS.26,32-34
Patient activation is a broad concept that encompasses pa-
tient engagement, empowerment and partnership working.33
Four levels of patient activation have been described, where the
individual (1) does not play an active role in their health; (2) does
play a role but lacks confidence or knowledge; (3) is beginning
to take action to improve their health; or (4) is able to self-man-
age and self-care.33 Cross-sectional studies suggested that
poorer patient activation may be associated with poorer out-
comes in the general population as well as in people with dia-
betes.10,35 We did not use a validated patient activation measure
tool,36 which was beyond the remit of our project, but we took
FPS and a failure to respond to the survey as indirect measures
of patient activation. This is a limitation of our study, but high-
lights the conundrum that formal measurement of patient acti-
vation can only be undertaken in those who engage in care. A
poor FPS score and low survey response may reflect poorer pa-
tient activation which may in turn be associated with measurable
increased risk. In the present study, non-response to the survey
(suggesting potentially poorer patient activation) was not only
significantly associated with a worse FPS as another marker of
activation, but also with adverse clinical risk as reflected by
HbA1c, BMI, cholesterol, smoking and primary CHD risk score. 
However, poorer patient activation, reflected in non-
response, does not mean that the information booklet is neces-
sarily ineffective in modifying that risk. Our preceding publication
clearly demonstrated a greater impact on diabetes access and
process measure outcomes in the poorer FPS categories.26 In-
creased access and process attainment, followed by subsequent
intervention, may therefore modify the adverse clinical profile in
these hard-to-reach patients.
In summary, people with diabetes are able to understand
their most important diabetes-related information when it is pre-
sented to them in a simple but structured format. The booklet is
easy to generate and its low-tech presentation belies the high
standard and governance of data integration and quality assur-
ance required to produce it. The booklet should be easily repro-
ducible in other health economies and it can be disseminated
independently of healthcare professionals and distributed sys-
tematically across a whole population. It provides for people with
diabetes an opportunity to reflect on their own status and take
action, facilitates their consultations with healthcare profession-
als25 and promotes patient activation, even amongst those with
a poorer baseline FPS score.26
Whether its prospective use improves key clinical diabetes
outcomes via the enhancement of patient activation remains a
key question. However, the ultimate intention of promoting
patient activation is that of improving measurable surrogate and
hard endpoint clinical outcomes. We hope to address this in the
final analysis of our current RCT at 1 year post-intervention,
potentially influencing the relationship between poorer patient
activation and adverse clinical risk. 
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Figure 1. Mean±SEM Framingham 10-year primary CHD risk
score (%) in those who did or did not respond to 
the questionnaire.
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Key messages
• People with diabetes like to receive personalised
information about their diabetes in a simple, but
structured, format
• Such information can promote users to play an active
role in partnership with their healthcare professionals
• A poor response may reflect poor patient activation
and is associated with increased risk of coronary
heart disease
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Study registration The study was registered in the UK national research
database (UK CRN ref: DRN 795, available at http://public.ukcrn.org.uk/ Search/
StudyDetail.aspx?StudyID=14324) and at clinicaltrials.gov (NCT02200965). Eth-
ical permission was obtained from NHS Health Research Authority (NRES com-
mittee North East-York, REC Ref: 13/NE/0052) and further clarification was
obtained from National Information Governance Board..
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